» Articles » PMID: 28741963

Effects of Parathyroidectomy on Bone Metabolism in Haemodialysis Patients with Secondary Hyperparathyroidism

Overview
Publisher Informa Healthcare
Specialty Science
Date 2017 Jul 26
PMID 28741963
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the outcome of bone metabolism and bone mineral density (BMD) in haemodialysis patients after parathyroidectomy (PTX).

Methods: A total of 31 haemodialysis patients with secondary hyperparathyroidism (SHPT) were treated with PTX. BMD of lumbar spine (LS) and femoral neck (FN) was determined by dual energy X-ray absorptiometry.

Results: Parathyroidectomy ledds to significant decrease of serum β-crosslaps (β-CTX), osteocalcin (OC) and procollagen type I amino-terminal propeptide (PINP) while serum sclerostin (SOST) increased after surgery. BMD was markedly improved in both LS and FN after PTX. Z-scores analysis further confirmed that PTX significantly benefited bone metabolism in haemodialysis patients, which well correlated with the improvement of serum iPTH and OC.

Conclusions: Parathyroidectomy leads to significant improvement of serum OC, PINP, β-CTX and SOST, which may beneficially modify calcium-phosphorus metabolism and BMD in haemodialysis patients with SHPT.

Citing Articles

Study on the correlation between mineral bone metabolism and CRP in patients with SHPT during perioperative period.

Yan L, Xiong Q, Xu Q, Ren P, Li T, Cao H Immun Inflamm Dis. 2023; 11(4):e828.

PMID: 37102663 PMC: 10091369. DOI: 10.1002/iid3.828.


Different outcomes following parathyroidectomy in patients with uremic tumoral calcinosis: two case reports.

Li J, Li X, Dong X, Ma L, Guo Z, Chen X BMC Nephrol. 2023; 24(1):55.

PMID: 36922797 PMC: 10018971. DOI: 10.1186/s12882-023-03107-3.


Risk Factors for Severe Hypocalcemia in Patients with Secondary Hyperparathyroidism after Total Parathyroidectomy.

Wen P, Xu L, Zhao S, Gan W, Hou D, Zhang L Int J Endocrinol. 2021; 2021:6613659.

PMID: 33868402 PMC: 8035008. DOI: 10.1155/2021/6613659.


Analyzing clinical characteristics of patients with different cumulative hemodialysis durations: a cross-sectional study.

Chen X, Yuan L, Zhang Y, Dai H, Fan Y, Chen X PeerJ. 2021; 9:e10852.

PMID: 33732543 PMC: 7953870. DOI: 10.7717/peerj.10852.


Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease.

Rodriguez-Ortiz M, Rodriguez M F1000Res. 2020; 9.

PMID: 32913635 PMC: 7463297. DOI: 10.12688/f1000research.22636.1.